STAT3 pathway inhibitors

Product Name Product Description Specification
SL#024 STAT-3 inhibitors
Release: 06/21/2016

STAT3 signaling is frequently activated in malignant cells leading to over-expression and accumulation of anti-apoptotic proteins. [1]. STAT3 is the lowest point of fusion of many signaling pathways, thus providing an attractive target for therapeutic intervention in the treatment of cancer [2].

In library: STAT3 pathway inhibitors